ArticleThe oncologist2022

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma.

Wenwu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.